》日本患者由来がんモデル学会学術集会２０２２

2022/11/18

1. 田中利男、患者がん移植モデル（PDX）とターゲットバリデーション、実験医学増刊号2022 年12 月刊行
予定
2. 田中利男、小岩純子、次世代ゼブラフィッシュ創薬とプレシジョンメディシン、日薬理誌　2019 年　第
154 巻　P78–83
3. Shimada Y, Nishimura Y, Tanaka T. Zebrafish-based systems pharmacology of cancer metastasis. Methods Mol Biol.
2014; 1165: 223–38.
4. Zhang B, Shimada Y, Hirota T, Ariyoshi M, Kuroyanagi J, Nishimura Y, Tanaka T. Novel immunologic tolerance of
human cancer cell xenotransplants in zebrafish. Transl Res. 2016 Apr; 170: 89–98. e3.
5. Zhang B, Shimada Y, Kuroyanagi J, Ariyoshi M, Nomoto T, Shintou T, Umemoto N, Nishimura Y, Miyazaki T, Tanaka
T. In vivo selective imaging and inhibition of leukemia stem-like cells using the fluorescent carbocyanine derivative,
DiOC5(3). Biomaterials. 2015 Jun; 52: 14–25.
6. Zhang B, Shimada Y, Kuroyanagi J, Nishimura Y, Umemoto N, Nomoto T, Shintou T, Miyazaki T,Tanaka T. Zebrafish
xenotransplantation model for cancer stem-like cell study and high-throughput screening of inhibitors. Tumour Biol.
2014 Dec; 35(12): 11861–9.
7. Zhang B, Shimada Y, Kuroyanagi J, Umemoto N, Nishimura Y, Tanaka T. Quantitative phenotyping-based in vivo
chemical screening in a zebrafish model of leukemia stem cell xenotransplantation. PLoS One. 2014 Jan 15; 9(1):
e85439.
8. Kuroyanagi J, Shimada Y, Zhang B, Ariyoshi M, Umemoto N, Nishimura Y, Tanaka T. Zinc finger MYND-type containing
8 promotes tumour angiogenesis via induction of vascular endothelial growth factor-A expression. FEBS Lett.
2014 Sep 17; 588(18): 3409–16.

EVENTS

》日本患者由来がんモデル学会学術集会２０２２

関連リンク